MedPlus Health Services Limited (MEDPLUS.BO)
INR 848.85
(-1.74%)
INR 848.85
(-1.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 56.24 Billion | 45.28 Billion | 37.55 Billion | 30.5 Billion | 28.51 Billion | 22.58 Billion |
| Cost of Revenue | 43.91 Billion | 35.57 Billion | 29.82 Billion | 24.25 Billion | 23.37 Billion | 18.45 Billion |
| Gross Profit | 12.33 Billion | 9.7 Billion | 7.73 Billion | 6.25 Billion | 5.13 Billion | 4.13 Billion |
| Operating Expenses | 2.42 Billion | 8.83 Billion | 6.16 Billion | 4.96 Billion | 4.21 Billion | 3.51 Billion |
| Selling, General and Administrative Expenses | 6.5 Billion | 887.09 Million | 642.28 Million | 434.36 Million | 486.65 Million | 487.39 Million |
| Research and Development Expenses | - | - | - | 2.09 Million | 2.47 Million | 3.02 Million |
| Other Expenses | - | 112.34 Million | 103.48 Million | 111.46 Million | 81.4 Million | 84.2 Million |
| Cost and Expenses | 54.92 Billion | 44.41 Billion | 35.98 Billion | 29.22 Billion | 27.59 Billion | 21.96 Billion |
| Operating Income | 1.31 Billion | 860.68 Million | 1.54 Billion | 1.29 Billion | 919.41 Million | 619.11 Million |
| Interest Expense | 964.33 Million | 830.27 Million | 664.28 Million | 536.17 Million | 460.72 Million | 480.08 Million |
| Income Tax Expense | 78.66 Million | -29.42 Million | 232.27 Million | 319.87 Million | 275.65 Million | 108.29 Million |
| Earnings before Tax | 734.43 Million | 471.63 Million | 1.17 Billion | 950.98 Million | 293.59 Million | 227.51 Million |
| Net Income | 654.73 Million | 497.63 Million | 958.02 Million | 638.58 Million | 21.8 Million | 119.21 Million |
| Earnings Per Share Basic | 5.45 | 4.17 | 15.97 | 6.26 | 1.05 | 0.77 |
| Earnings Per Share Diluted | 5.45 | 4.16 | 8.55 | 6.13 | 1.01 | 0.77 |
| Weighted Average Shares Outstanding | 120.13 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.02 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million |
| Gross Margin | 0.22 | 0.21 | 0.21 | 0.21 | 0.18 | 0.18 |
| EBIT Margin | 0.07 | 0.07 | 0.08 | 0.08 | 0.06 | 0.06 |
| Profit Margin | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 |
| EBITDA | 3.94 Billion | 3.11 Billion | 3.03 Billion | 2.38 Billion | 1.5 Billion | 1.31 Billion |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.04 | 0.04 | 0.03 | 0.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 14.88 Billion | 12.52 Billion | 45.57 Billion | 14.41 Billion | 14.08 Billion | 12.84 Billion |
| Cost of Revenue | 13.81 Billion | 9.69 Billion | 35.57 Billion | 11.22 Billion | 11.04 Billion | 10.1 Billion |
| Gross Profit | 1.07 Billion | 2.83 Billion | 9.99 Billion | 3.18 Billion | 3.04 Billion | 2.73 Billion |
| Operating Expenses | 736.71 Million | 2.57 Billion | 9.15 Billion | 2.84 Billion | 2.74 Billion | 2.54 Billion |
| Selling, General and Administrative Expenses | 736.71 Million | 1.48 Billion | - | 674.25 Million | 616.06 Million | 544.61 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 87.12 Million | 104.59 Million | 400.08 Million | 97.91 Million | 103.65 Million | 93.93 Million |
| Cost and Expenses | 14.55 Billion | 14.43 Billion | 54.94 Billion | 14.06 Billion | 13.78 Billion | 12.65 Billion |
| Operating Income | 337.33 Million | 258.29 Million | 841.12 Million | 346.69 Million | 296.18 Million | 189.29 Million |
| Interest Expense | 246.58 Million | 222.69 Million | 830.27 Million | 244.98 Million | 235.39 Million | 232.71 Million |
| Income Tax Expense | 34.43 Million | -93.05 Million | -29.42 Million | 62.57 Million | 19 Million | 12.86 Million |
| Earnings before Tax | 177.87 Million | 172.54 Million | 471.63 Million | 199.62 Million | 164.44 Million | 50.51 Million |
| Net Income | 143.63 Million | 265.82 Million | 497.63 Million | 137.26 Million | 145.64 Million | 37.86 Million |
| Earnings Per Share Basic | 1.20 | 1.71 | - | 1.15 | 1.22 | 0.32 |
| Earnings Per Share Diluted | 1.20 | 1.71 | - | 1.14 | 1.21 | 0.32 |
| Weighted Average Shares Outstanding | 119.31 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.31 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million | 155.4 Million |
| Gross Margin | 0.07 | 0.23 | 0.22 | 0.22 | 0.22 | 0.21 |
| EBIT Margin | 0.06 | 0.08 | - | 0.07 | 0.07 | 0.06 |
| Profit Margin | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| EBITDA | 937.63 Million | 1.05 Billion | - | 1.01 Billion | 954.56 Million | 807.37 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
JAYBARMARU
MKTX
CBOE
RTH
LALIN
3741